|
Report Date : |
06.04.2014 |
IDENTIFICATION DETAILS
|
Name : |
SHINWA BUSSAN CO LTD |
|
|
|
|
Registered Office : |
1-5-3 Doshomachi Chuoku Osaka 541-0045 |
|
|
|
|
Country : |
Japan |
|
|
|
|
Financials (as on) : |
30.04.2013 |
|
|
|
|
Date of Incorporation : |
July, 1959 |
|
|
|
|
Com. Reg. No.: |
1200-01-012620 (Osaka-Higashinariku) |
|
|
|
|
Legal Form : |
Limited Company (Kabushiki Kaisha) |
|
|
|
|
Line of Business : |
Import, wholesale of herbal drugs, crude drugs, other |
|
|
|
|
No. of Employees |
14 |
RATING & COMMENTS
|
MIRA’s Rating : |
B |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
COMPANY NAME AND ADDRESS
SHINWA BUSSAN CO
LTD
REGD NAME: Shinwa Bussan KK
MAIN OFFICE
1-5-3 Doshomachi Chuoku Osaka 541-0045 JAPAN
Tel: 06-6202-4571 Fax: 06-6202-4674
*.. Registered at: 4-14-18 Nakamichi Higashinariku Osaka
URL: http://www.shinwa-bussan.co.jp
E-Mail address: info@shinwa-bussan.co.jp
ACTIVITIES
Import, wholesale of herbal drugs, crude drugs, other
BRANCHES
Osaka (pharmacy)
OVERSEAS
China, India, Brazil, Australia, other (partners
OFFICERS
KOSHI MARUYAMA, PRES
Yen Amount: In million Yen,
unless otherwise stated
SUMMARY
FINANCES FAIR A/SALES Yen 3,150 M
PAYMENTS SLOW BUT CORRECT CAPITAL Yen
20 M
TREND SLOW WORTH Yen 398 M
STARTED 1959 EMPLOYES 14
COMMENT
TRADING FIRM SPECIALIZING IN HERBAL DURGS, CRUDE DRUGS
FINANCIAL SITUATION CONSIDERED FAIR AND GOOD FOR ORDINARY BUSINESS
ENGAGEMENTS.
MAX CREDIT LIMIT: YEN 66.5 MILLION, 30 DAYS NORMAL TERMS
HIGHLIGHTS
The subject company was established originally in 1923 by Kikunosuke
Inoue, on his account, for selling Chinese herbal medicines. Incorporated in 1959, the firm has been
succeeded by the present executives.
This is a trading for import, export and wholesale of Chinese herbal
medicines, crude drugs, other. Materials
and goods are imported from China, India, Brazil, Australia, other. Has a drug store in Osaka selling these
products.
FINANCIAL
INFORMATION
Financials are only partially disclosed.
The sales volume for Apr/2013 fiscal term amounted to Yen 3,150 million,
a 5% down from Yen 3,300 million in the previous term. The net profit was posted at Yen 8 million,
compared with Yen 11 million a year ago.
For the current term ending Apr 2014 the net profit is projected at Yen
10 million, on a 3% rise in turnover, to Yen 3,250 million.
The financial situation is considered FAIR and good for ORDINARY
business engagements. Max credit limit is
estimated at Yen 66.5 million, on 30 days normal terms.
REGISTRATION
Date
Registered: Jul 1959
Regd
No.: 1200-01-012620
(Osaka-Higashinariku)
Legal
Status: Limited
Company (Kabushiki Kaisha)
Authorized: 160,000 shares
Issued: 40,000
shares
Sum:
Yen
20 million
Major
shareholders (%): Koshi Maruyama (62.5),
Kikuko Maruyama (17.5)
No.
of shareholders: 7
Nothing detrimental is known as to the
commercial morality of executives.
OPERATION
Activities: Imports, exports,
wholesales and retails Chinese herbal drugs, crude drugs, drug materials, other
(--100%)
Clients: [Mfrs,
wholesalers] Mitsuboshi Pharmaceutical, Alps Pharmaceutical Ind, Maruzen
Pharmaceuticals, other
Exports to Korea, China, other
No. of accounts: 350
Domestic areas of activities: Nationwide
Suppliers: [Mfrs,
wholesalers] Imports from China, Korea, India, Brazil, Australia, other.
Domestically supplied from Alps
Pharmaceutical Ind, other
Payment
record: Slow but Correct
Location: Business area in
Osaka. Office premises at the caption
address are leased and maintained satisfactorily.
Bank
References:
Resona Bank (Midosuji)
Kansai Urban Bank (H/O)
Relations: Satisfactory
FINANCES
(In Million Yen)
|
Terms Ending: |
|
30/04/2014 |
30/04/2013 |
30/04/2012 |
30/04/2011 |
|
Annual Sales |
|
3,250 |
3,150 |
3,300 |
3,000 |
|
Recur. Profit |
|
.. |
.. |
.. |
.. |
|
Net Profit |
|
10 |
8 |
11 |
10 |
|
Total Assets |
|
|
N/A |
N/A |
N/A |
|
Net Worth |
|
|
398 |
390 |
379 |
|
Capital, Paid-Up |
|
|
20 |
20 |
20 |
|
Div.P.Share(¥) |
|
|
0.00 |
0.00 |
0.00 |
|
<Analytical Data> |
(%) |
(%) |
(%) |
(%) |
|
|
S.Growth Rate |
3.17 |
-4.55 |
10.00 |
-6.25 |
|
|
Current Ratio |
.. |
.. |
.. |
||
|
N.Worth Ratio |
.. |
.. |
.. |
||
|
N.Profit/Sales |
0.31 |
0.25 |
0.33 |
0.33 |
|
Notes: Financials are only partially disclosed.
Forecast (or estimated) figures for the 30/04/2014 fiscal term.
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
|
56-70 |
A |
Financial & operational base are regarded healthy. General unfavourable
factors will not cause fatal effect. Satisfactory capability for payment of
interest and principal sums |
Fairly Large |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
|
26-40 |
B |
Capability to
overcome financial difficulties seems comparatively below average. |
Small |
|
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
|
-- |
NB |
New Business |
-- |
|
This score serves as a reference to assess SC’s
credit risk and to set the amount of credit to be extended. It is calculated
from a composite of weighted scores obtained from each of the major sections of
this report. The assessed factors and their relative weights (as indicated
through %) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend (10%) Operational size
(10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or
its officials.